201 related articles for article (PubMed ID: 31591940)
1. Teprenone for the prevention of low-dose aspirin-induced gastric mucosal injury in
Chitapanarux T; Lertprasertsuke N; Kongnak A
Scand J Gastroenterol; 2019 Oct; 54(10):1199-1204. PubMed ID: 31591940
[No Abstract] [Full Text] [Related]
2. Teprenone improves gastric mucosal injury and dyspeptic symptoms in long-term nonsteroidal anti-inflammatory drug users.
Gong Y; Huang X; Chen M; Xiong L
J Gastroenterol Hepatol; 2019 Aug; 34(8):1344-1350. PubMed ID: 30681185
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J; Saito Y; Honda A; Matsuzaki Y
World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
[TBL] [Abstract][Full Text] [Related]
4. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
Tozawa K; Oshima T; Okugawa T; Ogawa T; Ohda Y; Tomita T; Hida N; Fukui H; Hori K; Watari J; Nakamura S; Miwa H
Dig Dis Sci; 2014 Aug; 59(8):1885-90. PubMed ID: 24659236
[TBL] [Abstract][Full Text] [Related]
6. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.
Sanuki T; Fujita T; Kutsumi H; Hayakumo T; Yoshida S; Inokuchi H; Murakami M; Matsubara Y; Kuwayama H; Kawai T; Miyaji H; Fujisawa T; Terao S; Yamazaki Y; Azuma T;
J Gastroenterol; 2012 Nov; 47(11):1186-97. PubMed ID: 22526273
[TBL] [Abstract][Full Text] [Related]
7. Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin.
Takeuchi T; Ota K; Harada S; Kojima Y; Inoue T; Iwakiri R; Sakata Y; Fujimoto K; Fujita T; Azuma T; Higuchi K
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():11-5. PubMed ID: 25521726
[TBL] [Abstract][Full Text] [Related]
8. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
9. [Preventive effects of teprenone on gastric mucosal lesions induced by Helicobacter pylori in mice].
Yang GB; Hu FL; Mu FH
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):992-5. PubMed ID: 16759543
[TBL] [Abstract][Full Text] [Related]
10. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
[TBL] [Abstract][Full Text] [Related]
12. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
Iijima K; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.
Shim KN; Kim JI; Kim N; Kim SG; Jo YJ; Hong SJ; Shin JE; Kim GH; Park KS; Choi SC; Kwon JG; Kim JH; Kim HJ; Kim JW
Korean J Intern Med; 2019 Sep; 34(5):1008-1021. PubMed ID: 29847892
[TBL] [Abstract][Full Text] [Related]
14. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin.
Nakashima S; Ota S; Arai S; Yoshino K; Inao M; Ishikawa K; Nakayama N; Imai Y; Nagoshi S; Mochida S
World J Gastroenterol; 2009 Feb; 15(6):727-31. PubMed ID: 19222098
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2.
Tamura A; Murakami K; Kadota J;
BMC Res Notes; 2013 Mar; 6():116. PubMed ID: 23531145
[TBL] [Abstract][Full Text] [Related]
17. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
Miyake K; Tsukui T; Shinji Y; Shinoki K; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Gudis K; Iwakiri K; Yamada N; Sakamoto C
Helicobacter; 2004 Apr; 9(2):130-7. PubMed ID: 15068414
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Iijima K; Shimosegawa T
Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
[TBL] [Abstract][Full Text] [Related]
19. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
[No Abstract] [Full Text] [Related]
20. Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
Pittayanon R; Piyachaturawat P; Rerknimitr R; Prueksapanich P; Chaitongrat S; Lertsuwunseri V; Srimahachota S; Mahachai V
J Gastroenterol Hepatol; 2019 Sep; 34(9):1517-1522. PubMed ID: 30919492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
